The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

Ccng1  -  cyclin G1

Rattus norvegicus

Synonyms: CYCG, Ccng, Cyclin-G, Cyclin-G1
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Ccng1

 

High impact information on Ccng1

  • CONCLUSIONS: These findings represent the first demonstration of the inhibitory effects of an antisense cyclin G1 retroviral vector on nonneoplastic cell proliferation [3].
  • Retroviral vectors bearing an antisense cyclin G1 construct inhibited the proliferation of transduced aortic SMCs in 2- to 6-day cultures, concomitant with down-regulation of cyclin G1 protein expression and decreased [3H]thymidine incorporation into DNA [3].
  • Moreover, in vivo delivery of high-titer antisense cyclin G1 vector supernatant to the balloon-injured rat carotid artery in vivo resulted in a significant reduction in neointima formation [3].
  • Downregulation of cyclin G1 expression by retrovirus-mediated antisense gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation [3].
  • Pronounced "bystander effects" including neighboring cells were noted in aortic SMCs transduced with the antisense cyclin G1 vector, as determined by quantitative assays and fluorescent labeling of nontransduced cells [3].
 

Biological context of Ccng1

  • Cyclin G mRNA is induced within 3 h after growth stimulation and remains elevated with no apparent cell cycle dependency, indicating its close association with growth stimuli but not with the cell cycle [4].
  • Identification of p53 target genes through immune selection of genomic DNA: the cyclin G gene contains two distinct p53 binding sites [5].
  • The selective up-regulation of cyclin G1 and p21 in neurons in the border zone of a focal ischemic infarct indicates their involvement in an adaptive response to ischemic injury [1].
  • The possible participation of cyclin G1 and p21 in a signal transduction pathway associated with ischemia-induced cellular stress is discussed [1].
  • The nonoverlapping temporal and spatial expression patterns of p53 and its transcriptional targets Bax, cyclin G1 and p21Waf1 suggest that each of these gene products fulfill independent roles in brain morphogenesis [6].
 

Anatomical context of Ccng1

  • Cyclin G1 immunoreactivity was constitutively expressed in the nuclei of cells in the choroid plexus and ependymal cell layer and in the cytoplasm of cell bodies and dendrites of pyramidal neurons of the cerebral cortex [1].
  • Cyclin G1 messenger RNA and protein levels transiently increased to 150% of contralateral levels in neurons of the ipsilateral frontal and parietal cortex and striatum 3 h following middle cerebral artery occlusion [1].
  • Decreased cyclin A2 and increased cyclin G1 levels coincide with loss of proliferative capacity in rat Leydig cells during pubertal development [7].
  • Cyclin G1 and p21WAF1/CIP1 mRNA levels increased significantly between 2.5 and 4-fold in neurons of the hippocampus, cortex, and striatum during the first 24 hr after reperfusion and decreased at 48 hr of reperfusion [2].
  • Whereas mRNA and protein levels of PP2A B' subunits were high in the cortical plate, subiculum, hippocampal areas and thalamus at E20 and decreased with age, those of cyclin G1 increased with age and were maximal in the adult cortex and hippocampus [8].
 

Associations of Ccng1 with chemical compounds

  • RESULTS: In whole testis extracts, increases in Gadd45, p21 and cyclin-G expression were detectable after irradiation, but not after etoposide or adriamycin treatments [9].
  • Recently, cyclin G1 has been shown to interact with the B' subunits of serine/threonine protein phosphatase 2A (PP2A) in a rat fibroblast cell line [K. Okamoto, C., Kamibayashi, M. Serrano, C. Prives, M.C. Mumby, D. Beach, p53-dependent association between cyclin G and the B' subunit of protein phosphatase 2A, Mol. Cell. Biol. 16 (1996) 6593-6602] [8].
 

Other interactions of Ccng1

  • Those genes whose expression was increased by functional p53 include RAS, U6 snRNA, cyclin G, EGR-1, and several novel genes [10].
  • HGF treatment increased cyclin A, cyclin G1 and nuclear transcriptional factor (NFkappaB) protein expression [11].
  • In rat 14-day-old embryonic cortical cultures, cyclin G1 and PP2A B'alpha protein co-localized in nuclear and perinuclear areas of neurons, and both proteins were highly expressed in nuclei of cortical and hippocampal pyramidal cells and the mitral cell layer of the neonatal olfactory bulb [8].
 

Analytical, diagnostic and therapeutic context of Ccng1

References

  1. Cell cycle-related gene expression in the adult rat brain: selective induction of cyclin G1 and p21WAF1/CIP1 in neurons following focal cerebral ischemia. van Lookeren Campagne, M., Gill, R. Neuroscience (1998) [Pubmed]
  2. Increased expression of cyclin G1 and p21WAF1/CIP1 in neurons following transient forebrain ischemia: comparison with early DNA damage. van Lookeren Campagne, M., Gill, R. J. Neurosci. Res. (1998) [Pubmed]
  3. Downregulation of cyclin G1 expression by retrovirus-mediated antisense gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation. Zhu, N.L., Wu, L., Liu, P.X., Gordon, E.M., Anderson, W.F., Starnes, V.A., Hall, F.L. Circulation (1997) [Pubmed]
  4. Cyclin G: a new mammalian cyclin with homology to fission yeast Cig1. Tamura, K., Kanaoka, Y., Jinno, S., Nagata, A., Ogiso, Y., Shimizu, K., Hayakawa, T., Nojima, H., Okayama, H. Oncogene (1993) [Pubmed]
  5. Identification of p53 target genes through immune selection of genomic DNA: the cyclin G gene contains two distinct p53 binding sites. Zauberman, A., Lupo, A., Oren, M. Oncogene (1995) [Pubmed]
  6. Tumor-suppressor p53 is expressed in proliferating and newly formed neurons of the embryonic and postnatal rat brain: comparison with expression of the cell cycle regulators p21Waf1/Cip1, p27Kip1, p57Kip2, p16Ink4a, cyclin G1, and the proto-oncogene Bax. van Lookeren Campagne, M., Gill, R. J. Comp. Neurol. (1998) [Pubmed]
  7. Decreased cyclin A2 and increased cyclin G1 levels coincide with loss of proliferative capacity in rat Leydig cells during pubertal development. Ge, R.S., Hardy, M.P. Endocrinology (1997) [Pubmed]
  8. Developmental expression and co-localization of cyclin G1 and the B' subunits of protein phosphatase 2a in neurons. van Lookeren Campagne, M., Okamoto, K., Prives, C., Gill, R. Brain Res. Mol. Brain Res. (1999) [Pubmed]
  9. Stage-specific expression of Gadd45 induced by X-irradiation in rat spermatogenesis. West, A., Priante, G., Lähdetie, J. Int. J. Radiat. Biol. (2002) [Pubmed]
  10. SAGE transcript profiles for p53-dependent growth regulation. Madden, S.L., Galella, E.A., Zhu, J., Bertelsen, A.H., Beaudry, G.A. Oncogene (1997) [Pubmed]
  11. HGF-mediated apoptosis via p53/bax-independent pathway activating JNK1. Conner, E.A., Teramoto, T., Wirth, P.J., Kiss, A., Garfield, S., Thorgeirsson, S.S. Carcinogenesis (1999) [Pubmed]
 
WikiGenes - Universities